The National charity ‘Antibiotic Research UK (ANTRUK) is commissioning its first ever research programme to screen antibiotic resistance breakers against antibiotic resistance in Gram-negative bacteria in order to meet the challenges of the rise in antibiotic resistance (Super-bug).
This is the first of five projects to be carried out in the next 5 to 7 years with the ultimate objective of developing new antibiotic therapies for use by the early 2020’s to overcome Super-bugs.
ANTRUK goal is to also reverse the decline in antibiotic drug development particularly given the lack of appetite among ‘Big pharma’ to find new therapy since the WHO’s UK Chief Medical Officer, Dan Sally Davies and Prime Minister believe that antibiotics resistance threatens a global situation as serious as the AIDS epidemic.
No Comments